生物标誌物测试服务全球市场规模调查和预测：按产品（生物标誌物分析开发,流式细胞术等）,最终用户（製药/生物技术公司,研究机构,CRO）,地区分析2022-2029

2021 年全球生物标誌物检测服务市场价值约为 7.596 亿美元，并预计在 2022-2029 年预测期内以超过 6.9% 的健康增长率增长。

生物标誌物检测服务提供了一种测量生物过程的强大方法，不仅可以作为对药理干预做出反应的正常状态的指标，还可以作为病理状态的指标。 长期以来，医生们一直使用血液和其他体液中 DNA 或蛋白质水平的生物标誌物分析来研究人类疾病。 癌症、免疫反应、遗传疾病和心血管疾病等临床疾病是医生经常使用生物标记服务识别和治疗的疾病。 由于对癌症检测的生物标誌物测试需求增加以及研发活动增加等因素，生物标誌物测试服务市场正在扩大。

正在发现用于研究和开发的新生物标誌物。 例如，在 2020 年，sTNFR2 被确定为用于诊断急性成人 T 细胞白血病/淋巴瘤的新型生物标誌物。 同样，2018 年，FDA 批准了疟原虫 18S rRNA/rDNA 生物标誌物用于治疗疟疾。 由于这些发现和技术改进，市场预计在预测期内将实现盈利增长。 如果该产品成功推出，它可能会为患者提供另一种选择。 此外，临床研究中对生物标誌物的需求不断增加，慢性病和传染病负担的增加支持对生物标誌物检测的需求，正在推动市场实现利润丰厚的增长。 然而，生物标誌物检测服务的高成本和高资本投资以及生物标誌物开发的长期时间表将阻碍整个 2022-2029 年预测期内的市场增长。

全球生物标誌物检测服务市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于主要市场参与者的存在不断增加、实验室诊断测试的增加以及与生活方式相关的疾病的流行等因素，北美占据了市场份额。 CDC预测，2020年北美约有3730万糖尿病患者，其中2870万确诊，850万未确诊。 老年人和目标人群的增长、生物仿製药开发研究合作的增加、主要参与者的地域扩张以及政府机构和非营利组织对市场空间的积极参与将在预测期内推动亚太地区的增长。这些只是其中的一小部分该地区有望实现显着增长的因素。

这项研究的目的是揭示近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年各细分市场的全球市场估计和预测
  • 生物标誌物检测服务市场：按地区划分，2019-2029 年
  • 生物标誌物检测服务市场：按产品分类，2019-2029 年
  • 生物标誌物检测服务市场：按最终用户分类，2019-2029 年
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章生物标誌物检测服务的全球市场定义和范围

• 调查的目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第 3 章全球生物标誌物检测服务市场动态

• 生物标誌物检测服务市场影响分析 (2019-2029)
  • 市场驱动因素
    • 对用于癌症检测的生物标誌物检测的需求增加
    • 增加研发活动
  • 市场挑战
    • 生物标誌物检测服务成本高
    • 生物标誌物开发的资本投资高且时间长
  • 市场机会
    • 慢性病和传染病负担的增加支持对生物标誌物检测的需求

第 4 章全球生物标誌物检测服务市场行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 投资招聘模式
• 分析师的结论和建议
• 顶级投资机会
• 关键成功策略

第 5 章风险评估：COVID-19 的影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球生物标誌物检测服务市场：按产品分类

• 市场概况
• 生物标誌物检测服务的全球市场：按产品、性能潜力分析
• 2019-2029 年全球生物标誌物检测服务市场、按产品估算和预测
• 生物标誌物检测服务市场，细分分析
  • 生物标誌物分析开发
  • 流式细胞术
  • 其他

第 7 章：全球生物标誌物检测服务市场，按最终用户分类

• 市场概况
• 生物标誌物测试服务的全球市场：最终用户的性能潜力分析
• 2019-2029 年最终用户的生物标誌物测试服务全球市场、估计和预测
• 生物标誌物检测服务市场，细分分析
  • 製药公司、生物技术公司
  • 研究机构
  • 首席风险官

第 8 章全球生物标誌物检测服务市场：区域分析

• 生物标誌物检测服务市场，按地区划分的市场概况
• 北美
  • 美国
    • 2019-2029 年按产品估算和预测
    • 2019-2029 年最终用户的估计和预测
  • 加拿大
• 欧洲生物标誌物检测服务市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲地区
• 亚太生物标誌物检测服务市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲生物标誌物检测服务市场概况
  • 巴西
  • 墨西哥
• 世界其他地区

第 9 章衝突信息

• 顶级市场策略
• 公司简介
  • 生物 Agilytix 实验室
    • 主要信息
    • 概览
    • 财务信息（取决于数据可用性）
    • 产品概述
    • 近期趋势
  • Euro fins Scientific
  • SGS SA
  • Charles River Laboratories
  • Labcorp Drug Development
  • Thermo Fisher Scientific Inc.（PPD, Inc.）
  • ICON Plc
  • IQVIA
  • Syneos Health
  • Intertek Group Plc

第 10 章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查属性
• 调查先决条件

Global Biomarker Testing Services Market is valued at approximately USD 759.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2022-2029. Biomarker testing services give a powerful approach to measuring a biological process and act as an indicator in normal as well as pathological conditions in response to pharmacological intervention. To research human diseases, doctors have used biomarker analysis in blood or other body fluids at the DNA or protein level for many years. Clinical illnesses such as cancer, immunological responses, genetic disorders, and cardiovascular diseases are among the conditions that doctors frequently use biomarker services to identify and treat. The Biomarker Testing Services market is expanding because of factors such as increasing demand for biomarker testing for cancer detection and increasing R&D activities.

New biomarkers are being discovered because of research and development. For instance, sTNFR2 was identified as a novel biomarker for the diagnosis of acute adult T-cell leukemia/lymphoma in 2020. Similar to this, in 2018 the FDA approved the Plasmodium 18S rRNA/rDNA biomarker for the treatment of malaria. Due to these discoveries and technical improvements, the market is predicted to grow profitably during the forecast period. The successful launch of this product may provide patients with an alternative option. Furthermore, the growing demand for biomarkers in clinical studies and the growing burden of chronic and infectious diseases supporting demand for biomarker testing is creating lucrative growth in the market. However, the high cost of biomarker testing services and high capital investments and lengthy timelines for biomarker development stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Biomarker Testing Services Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market share owing to factors such as the rising presence of key market players, increase in laboratory diagnostic testing, and prevalence of lifestyle diseases. In 2020, the CDC projects that there may be about 37.3 million diabetes in the country, including 28.7 million cases that have been diagnosed and 8.5 million that have not. A growing geriatric and target population, an increase in the number of collaborations for biosimilar development, the geographic expansion of key players, and active participation by government and nonprofit organisations in the market space are just a few of the factors driving Asia Pacific's expected significant growth during the forecast period.

Major market players included in this report are:

Bio Agilytix Labs

Eurofins Scientific

SGS SA

Charles River Laboratories

Labcorp Drug Development

Thermo Fisher Scientific Inc. (PPD, Inc.)

ICON Plc

IQVIA

Syneos Health

Intertek Group Plc

Recent Developments in the Market:

• In April2021, Amgen announced the launch of Biomarker AssistTM, a programme to make biomarker testing more accessible to patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker AssistTM.
• In February 2022, oncodna introduced the launch of the oncodeep kit. a complete workflow solution is provided by the kit, permitting laboratories with ngs capabilities to perform comprehensive biomarker testing, provide powerful data analysis, and support oncologists in the most effective and personalized treatments for their cancer patients. For the quick analysis and reporting of a patient's tumor molecular profile, the offer will come in combination with oncodna's data analysis and clinical interpretation tools.

Global Biomarker Testing Services Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, End User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Biomarker Assay Development

Flow Cytometry

Others

By End User:

Pharmaceutical and biotechnology companies

Research Institutes

CRO

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Biomarker Testing Services Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Biomarker Testing Services Market, by Product, 2019-2029 (USD Million)
  • 1.2.3. Biomarker Testing Services Market, by End User, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Biomarker Testing Services Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Biomarker Testing Services Market Dynamics

• 3.1. Biomarker Testing Services Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing demand for biomarker testing for cancer detection
    • 3.1.1.2. Increasing R&D activities
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Biomarker Testing Services
    • 3.1.2.2. High capital investments and lengthy timelines for biomarker development
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing burden of chronic and infectious diseases supporting demand for biomarker testing

Chapter 4. Global Biomarker Testing Services Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biomarker Testing Services Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Biomarker Testing Services Market by Product, Performance - Potential Analysis
• 6.3. Global Biomarker Testing Services Market Estimates & Forecasts by Product 2019-2029 (USD Million)
• 6.4. Biomarker Testing Services Market, Sub Segment Analysis
  • 6.4.1. Biomarker Assay Development
  • 6.4.2. Flow Cytometry
  • 6.4.3. Others

Chapter 7. Global Biomarker Testing Services Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Biomarker Testing Services Market by End User, Performance - Potential Analysis
• 7.3. Global Biomarker Testing Services Market Estimates & Forecasts by End User 2019-2029 (USD Million)
• 7.4. Biomarker Testing Services Market, Sub Segment Analysis
  • 7.4.1. Pharmaceutical and biotechnology companies
  • 7.4.2. Research Institutes
  • 7.4.3. CRO

Chapter 8. Global Biomarker Testing Services Market, Regional Analysis

• 8.1. Biomarker Testing Services Market, Regional Market Snapshot
• 8.2. North America Biomarker Testing Services Market
  • 8.2.1. U.S. Biomarker Testing Services Market
    • 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Biomarker Testing Services Market
• 8.3. Europe Biomarker Testing Services Market Snapshot
  • 8.3.1. U.K. Biomarker Testing Services Market
  • 8.3.2. Germany Biomarker Testing Services Market
  • 8.3.3. France Biomarker Testing Services Market
  • 8.3.4. Spain Biomarker Testing Services Market
  • 8.3.5. Italy Biomarker Testing Services Market
  • 8.3.6. Rest of Europe Biomarker Testing Services Market
• 8.4. Asia-Pacific Biomarker Testing Services Market Snapshot
  • 8.4.1. China Biomarker Testing Services Market
  • 8.4.2. India Biomarker Testing Services Market
  • 8.4.3. Japan Biomarker Testing Services Market
  • 8.4.4. Australia Biomarker Testing Services Market
  • 8.4.5. South Korea Biomarker Testing Services Market
  • 8.4.6. Rest of Asia Pacific Biomarker Testing Services Market
• 8.5. Latin America Biomarker Testing Services Market Snapshot
  • 8.5.1. Brazil Biomarker Testing Services Market
  • 8.5.2. Mexico Biomarker Testing Services Market
• 8.6. Rest of The World Biomarker Testing Services Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Bio Agilytix Labs
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Euro fins Scientific
  • 9.2.3. SGS SA
  • 9.2.4. Charles River Laboratories
  • 9.2.5. Labcorp Drug Development
  • 9.2.6. Thermo Fisher Scientific Inc. (PPD, Inc.)
  • 9.2.7. ICON Plc
  • 9.2.8. IQVIA
  • 9.2.9. Syneos Health
  • 9.2.10. Intertek Group Plc

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Biomarker Testing Services Market, report scope
• TABLE 2. Global Biomarker Testing Services Market estimates & forecasts by Region 2019-2029 (USD Million)
• TABLE 3. Global Biomarker Testing Services Market estimates & forecasts by Product 2019-2029 (USD Million)
• TABLE 4. Global Biomarker Testing Services Market estimates & forecasts by End User 2019-2029 (USD Million)
• TABLE 5. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 6. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 7. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 8. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 9. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 10. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 11. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 12. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 13. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 14. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 15. U.S. Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 16. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 17. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 18. Canada Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 19. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 20. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 21. UK Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 22. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 23. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 24. Germany Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 25. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 26. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 27. France Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 28. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 29. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 30. Italy Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 31. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 32. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 33. Spain Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 34. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 35. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 36. RoE Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 37. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 38. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 39. China Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 40. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 41. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 42. India Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 43. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 44. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 45. Japan Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 46. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 47. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 48. South Korea Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 49. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 50. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 51. Australia Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 52. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 53. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 54. RoAPAC Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 55. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 56. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 57. Brazil Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 58. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 59. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 60. Mexico Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 61. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 62. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 63. RoLA Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 64. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 65. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 66. Row Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 67. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 68. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 69. List of secondary sources, used in the study of global Biomarker Testing Services Market
• TABLE 70. List of primary sources, used in the study of global Biomarker Testing Services Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Biomarker Testing Services Market, research methodology
• FIG 2. Global Biomarker Testing Services Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Biomarker Testing Services Market, key trends 2021
• FIG 5. Global Biomarker Testing Services Market, growth prospects 2022-2029
• FIG 6. Global Biomarker Testing Services Market, porters 5 force model
• FIG 7. Global Biomarker Testing Services Market, pest analysis
• FIG 8. Global Biomarker Testing Services Market, value chain analysis
• FIG 9. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 10. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 11. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 12. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 13. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 14. Global Biomarker Testing Services Market, regional snapshot 2019 & 2029
• FIG 15. North America Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 16. Europe Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 17. Asia pacific Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 18. Latin America Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 19. Global Biomarker Testing Services Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable